Press Resease

Neurostimulation Devices Market by Product (Deep Brain Stimulation Devices, Spinal Cord Stimulation Devices, Gastric Electric Stimulation Devices, Vagus Nerve Stimulation Devices, Sacral Nerve Stimulation Devices, and Others), by Application (Parkinson’s Disease, Epilepsy, Pain Management, Essential Tremor, Urinary and Fecal Incontinence, Alzheimer’s, Ischemia, and Others), and by End-User (Hospitals, Scientific Research Laboratories, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 02-Apr-2019 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-3982 Status : Published

Global neurostimulation devices market expected to generate around USD 15,404 million by 2025, at a CAGR of around 12.9% between 2019 and 2025. New technologies are being developed and researches have been revealing more potential uses of this treatment. This, in turn, is fuelling the rising demand for safer and cost-effective treatment options.

Description

The report covers a forecast and an analysis of the neurostimulation devices market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the neurostimulation devices market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the neurostimulation devices market on a global level.

In order to give the users of this report a comprehensive view of the neurostimulation devices market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Neurostimulation Devices Market

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the neurostimulation devices market by segmenting the market based on product, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some leading players of the global neurostimulation devices market include Boston Scientific Corporation, Medtronic Inc., Cyberonics Inc., NeuroPace Inc., St. Jude Medical Inc., and NeuroSigma, Inc.

This report segments the global neurostimulation devices market into:

Global Neurostimulation Devices Market: Product Analysis

  • Deep Brain Stimulation Devices
  • Spinal Cord Stimulation Devices
  • Gastric Electric Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Others

Global Neurostimulation Devices Market: Application Analysis

  • Parkinson’s Disease
  • Epilepsy
  • Pain Management
  • Essential Tremor
  • Urinary and Fecal Incontinence
  • Alzheimer’s
  • Ischemia
  • Others

Global Neurostimulation Devices Market: End-User Analysis

  • Hospitals
  • Scientific Research Laboratories
  • Others

Global Neurostimulation Devices Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global neurostimulation devices market, 2016—2025 (USD Million)
    • 2.2. Global neurostimulation devices market: Snapshot
  •  
  • Chapter 3. Neurostimulation Devices Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global neurostimulation devices market drivers: impact analysis
      • 3.2.2. Growing demand for neurostimulation devices as an add-on therapy
      • 3.2.3. Increasing global prevalence of chronic diseases and high unmet medical needs in these disease segments
      • 3.2.4. The rising prevalence of lifestyle-induced disorders
      • 3.2.5. External funding for executing R&D activities
      • 3.2.6. Escalating demand for minimally invasive surgeries
    • 3.3. Market Restraints
      • 3.3.1. Global neurostimulation devices market restraints: impact analysis
      • 3.3.2. Risks associated with neurostimulation devices
      • 3.3.3. The presence of stringent device approval regulations
      • 3.3.4. Availability of external substitutes
    • 3.4. Opportunities
      • 3.4.1. Growth opportunities arising from emerging markets
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by product
      • 3.6.2. Market attractiveness analysis, by application
      • 3.6.3. Market attractiveness analysis, by end-user
      • 3.6.4. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Neurostimulation Devices Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global neurostimulation devices market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
    • 4.3. Price trend analysis
  •  
  • Chapter 5. Global Neurostimulation Devices Market - Product Analysis
    • 5.1. Global neurostimulation devices market: product overview
      • 5.1.1. Global neurostimulation devices market revenue share, by product, 2018 and 2025
    • 5.2. Deep Brain Stimulation Devices
      • 5.2.1. Global neurostimulation devices market for deep brain stimulation devices, 2016-2025 (USD Million)
    • 5.3. Spinal Cord Stimulation Devices
      • 5.3.1. Global neurostimulation devices market for spinal cord stimulation devices, 2016-2025 (USD Million)
    • 5.4. Gastric Electric Stimulation Devices
      • 5.4.1. Global neurostimulation devices market for gastric electric stimulation devices, 2016-2025 (USD Million)
    • 5.5. Vagus Nerve Stimulation Devices
      • 5.5.1. Global neurostimulation devices market for vagus nerve stimulation devices, 2016-2025 (USD Million)
    • 5.6. Sacral Nerve Stimulation Devices
      • 5.6.1. Global neurostimulation devices market for sacral nerve stimulation devices, 2016-2025 (USD Million)
    • 5.7. Others
      • 5.7.1. Global neurostimulation devices market for others, 2016-2025 (USD Million)
  •  
  • Chapter 6. Global Neurostimulation Devices Market - Application Analysis
    • 6.1. Global neurostimulation devices market: application overview
      • 6.1.1. Global neurostimulation devices market revenue share, by application, 2018 and 2025
    • 6.2. Parkinson's Disease
      • 6.2.1. Global neurostimulation devices market for Parkinson's disease, 2016-2025 (USD Million)
    • 6.3. Epilepsy
      • 6.3.1. Global neurostimulation devices market for epilepsy, 2016-2025 (USD Million)
    • 6.4. Pain Management
      • 6.4.1. Global neurostimulation devices market for pain management, 2016-2025 (USD Million)
    • 6.5. Essential Tremor
      • 6.5.1. Global neurostimulation devices market for essential tremor, 2016-2025 (USD Million)
    • 6.6. Urinary and Fecal Incontinence
      • 6.6.1. Global neurostimulation devices market for urinary and fecal incontinence, 2016-2025 (USD Million)
    • 6.7. Alzheimer's
      • 6.7.1. Global neurostimulation devices market for Alzheimer's, 2016-2025 (USD Million)
    • 6.8. Ischemia
      • 6.8.1. Global neurostimulation devices market for ischemia, 2016-2025 (USD Million)
    • 6.9. Others
      • 6.9.1. Global neurostimulation devices market for others, 2016-2025 (USD Million)
  •  
  • Chapter 7. Global Neurostimulation Devices Market - End-User Analysis
    • 7.1. Global neurostimulation devices market: End-User overview
      • 7.1.1. Global neurostimulation devices market revenue share, by End-User, 2018 and 2025
    • 7.2. Hospitals
      • 7.2.1. Global neurostimulation devices market for hospitals, 2016-2025 (USD Million)
    • 7.3. Scientific Research Laboratories
      • 7.3.1. Global neurostimulation devices market for scientific research laboratories, 2016-2025 (USD Million)
    • 7.4. Others
      • 7.4.1. Global neurostimulation devices market for others, 2016-2025 (USD Million)
  • Chapter 8. Global Neurostimulation Devices Market- Regional Analysis
    • 8.1. Global neurostimulation devices market: regional overview
      • 8.1.1. Global neurostimulation devices market revenue share, by region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America neurostimulation devices market revenue, by product, 2016-2025 (USD Million)
      • 8.2.2. North America neurostimulation devices market revenue, by application, 2016-2025 (USD Million)
      • 8.2.3. North America neurostimulation devices market revenue, by End-User, 2016-2025 (USD Million)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. neurostimulation devices market revenue, by product, 2016-2025 (USD Million)
        • 8.2.4.2. The U.S. neurostimulation devices market revenue, by application, 2016-2025 (USD Million)
        • 8.2.4.3. The U.S. neurostimulation devices market revenue, by End-User, 2016-2025 (USD Million)
      • 8.2.5. Canada
        • 8.2.5.1. Canada neurostimulation devices market revenue, by product, 2016-2025 (USD Million)
        • 8.2.5.2. Canada neurostimulation devices market revenue, by application, 2016-2025 (USD Million)
        • 8.2.5.3. Canada neurostimulation devices market revenue, by End-User, 2016-2025 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe neurostimulation devices market revenue, by product, 2016-2025 (USD Million)
      • 8.3.2. Europe neurostimulation devices market revenue, by application, 2016-2025 (USD Million)
      • 8.3.3. Europe neurostimulation devices market revenue, by End-User, 2016-2025 (USD Million)
      • 8.3.4. U.K.
        • 8.3.4.1. U.K. neurostimulation devices market revenue, by product, 2016-2025 (USD Million)
        • 8.3.4.2. U.K. neurostimulation devices market revenue, by application, 2016-2025 (USD Million)
        • 8.3.4.3. U.K. neurostimulation devices market revenue, by End-User, 2016-2025 (USD Million)
      • 8.3.5. Germany
        • 8.3.5.1. Germany neurostimulation devices market revenue, by product, 2016-2025 (USD Million)
        • 8.3.5.2. Germany neurostimulation devices market revenue, by application, 2016-2025 (USD Million)
        • 8.3.5.3. Germany neurostimulation devices market revenue, by End-User, 2016-2025 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France neurostimulation devices market revenue, by product, 2016-2025 (USD Million)
        • 8.3.6.2. France neurostimulation devices market revenue, by application, 2016-2025 (USD Million)
        • 8.3.6.3. France neurostimulation devices market revenue, by End-User, 2016-2025 (USD Million)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe neurostimulation devices market revenue, by product, 2016-2025 (USD Million)
        • 8.3.7.2. Rest of Europe neurostimulation devices market revenue, by application, 2016-2025 (USD Million)
        • 8.3.7.3. Rest of Europe neurostimulation devices market revenue, by End-User, 2016-2025 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific neurostimulation devices market revenue, by product, 2016-2025 (USD Million)
      • 8.4.2. Asia Pacific neurostimulation devices market revenue, by application, 2016-2025 (USD Million)
      • 8.4.3. Asia Pacific neurostimulation devices market revenue, by End-User, 2016-2025 (USD Million)
      • 8.4.4. China
        • 8.4.4.1. China neurostimulation devices market revenue, by product, 2016-2025 (USD Million)
        • 8.4.4.2. China neurostimulation devices market revenue, by application, 2016-2025 (USD Million)
        • 8.4.4.3. China neurostimulation devices market revenue, by End-User, 2016-2025 (USD Million)
      • 8.4.5. Japan
        • 8.4.5.1. Japan neurostimulation devices market revenue, by product, 2016-2025 (USD Million)
        • 8.4.5.2. Japan neurostimulation devices market revenue, by application, 2016-2025 (USD Million)
        • 8.4.5.3. Japan neurostimulation devices market revenue, by End-User, 2016-2025 (USD Million)
      • 8.4.6. India
        • 8.4.6.1. India neurostimulation devices market revenue, by product, 2016-2025 (USD Million)
        • 8.4.6.2. India neurostimulation devices market revenue, by application, 2016-2025 (USD Million)
        • 8.4.6.3. India neurostimulation devices market revenue, by End-User, 2016-2025 (USD Million)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific neurostimulation devices market revenue, by product, 2016-2025 (USD Million)
        • 8.4.7.2. Rest of Asia Pacific neurostimulation devices market revenue, by application, 2016-2025 (USD Million)
        • 8.4.7.3. Rest of Asia Pacific neurostimulation devices market revenue, by End-User, 2016-2025 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America neurostimulation devices market revenue, by product, 2016-2025 (USD Million)
      • 8.5.2. Latin America neurostimulation devices market revenue, by application, 2016-2025 (USD Million)
      • 8.5.3. Latin America neurostimulation devices market revenue, by End-User, 2016-2025 (USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil neurostimulation devices market revenue, by product, 2016-2025 (USD Million)
        • 8.5.4.2. Brazil neurostimulation devices market revenue, by application, 2016-2025 (USD Million)
        • 8.5.4.3. Brazil neurostimulation devices market revenue, by End-User, 2016-2025 (USD Million)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America neurostimulation devices market revenue, by product, 2016-2025 (USD Million)
        • 8.5.5.2. Rest of Latin America neurostimulation devices market revenue, by application, 2016-2025 (USD Million)
        • 8.5.5.3. Rest of Latin America neurostimulation devices market revenue, by End-User, 2016-2025 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa neurostimulation devices market revenue, by product, 2016-2025 (USD Million)
      • 8.6.2. The Middle East and Africa neurostimulation devices market revenue, by application, 2016-2025 (USD Million)
      • 8.6.3. The Middle East and Africa neurostimulation devices market revenue, by End-User, 2016-2025 (USD Million)
  •  
  • Chapter 9. Company Profiles
    • 9.1. Boston Scientific Corporation
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Medtronic, Inc.
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Cyberonics, Inc.
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. NeuroPace, Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. St. Jude Medical, Inc.
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. NeuroSigma, Inc.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments

Methodology

Free Analysis

Neurostimulation is also known as spinal cord stimulation, which is the delivery of low voltage electricity to the peripheral nerves or the dorsal column in the body safely. These implantable stimulators prevent pain signals from reaching the brain and replace them with soothing, tingling sensations, which are also known as paresthesia. These sensations cover the specific areas of the body where the pain is felt. Neurostimulation has been used since the last 50 years. Peripheral nerve stimulation is the first form of neurostimulation to be developed. However, it wasn’t very popular initially and was replaced by other techniques that stimulated the spinal cord.

New technologies are being developed and researches have been revealing more potential uses of this treatment. This, in turn, is fuelling the rising demand for safer and cost-effective treatment options. Moreover, the increasing prevalence of diseases that are treated with neurostimulation therapy is the major growth factor of the global neurostimulation devices market. In addition, the increasing number of FDA approvals for clinical trials in this area is also propelling the global neurostimulation devices market. As per the National Center for Health Statistics of the Centers for Disease Control and Prevention (CDC), in 2013, around 85,000 people died of Alzheimer’s. Additionally, annually, nearly 50 million people worldwide suffer from epilepsy, making it one of the most common neurological diseases globally. However, the lack of well-trained professionals and non-measurable outcomes are affecting the growth of the neurostimulation devices market globally. Alternatively, the need to provide safe and improved care to patients suffering from neurological disorders and government support in emerging countries are expected to generate new market opportunities over the forecast period.

Global Neurostimulation Devices Market

The global neurostimulation devices market is segmented on the basis of product, application, and end-user. Based on product, the neurostimulation devices market is classified into deep brain stimulation devices, gastric electric stimulation devices, spinal cord stimulation devices, vagus nerve stimulation devices, sacral nerve stimulation devices, and others. On the basis of application, the market is segmented into epilepsy, Parkinson's disease, pain management, essential tremor, urinary and fecal incontinence, Alzheimer’s, ischemia, and others. Based on end-user, the market includes hospitals, scientific research laboratories, and others.

By region, North America is anticipated to dominate the global neurostimulation devices market and hold a major market share in the future. The European neurostimulation devices market is likely to hold a major share in the future, due to the cost-effectiveness of clinical researches in the region, which is enabling the medical devices companies to introduce new devices in the market. In emerging markets like India, about 31 million people suffer from neurological disorders with the prevalence of around 2,500 patients per 10,000 patients. This is further boosting the neurostimulation devices market in the Asia Pacific region.

Some leading players of the global neurostimulation devices market include Boston Scientific Corporation, Medtronic Inc., Cyberonics Inc., NeuroPace Inc., St. Jude Medical Inc., and NeuroSigma, Inc.

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social